Home › Funds › Renaissance Technologies › CELU
Renaissance Technologies position in CELU
CELULARITY INC · Health Care
Latest position (Q3 2025)42.00K sh
Reported value held$86.94K
Portfolio Weight0.00%
First reportedQ4 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 23.80K | $31 | New |
| Q1 2023 | 80.20K | $50 | Add |
| Q2 2023 | 274.41K | $146 | Add |
| Q3 2023 | 543.40K | $121 | Add |
| Q4 2023 | 843.47K | $209 | Add |
| Q1 2024 | 29.77K | $156 | Reduce |
| Q2 2024 | 25.50K | $79.81K | Reduce |
| Q3 2024 | 23.38K | $69.44K | Reduce |
| Q4 2024 | 11.00K | $22.88K | Reduce |
| Q2 2025 | 12.20K | $23.91K | New |
| Q2 2025 | 12.20K | $23.91K | New |
| Q3 2025 | 42.00K | $86.94K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CELU
- Vanguard Group 676.65K sh · $751.08K · Q4 2025
- Geode Capital Management 167.15K sh · $99.96K · Q2 2026
- Citadel Advisors 99.05K sh · $59.22K · Q2 2026
- BlackRock Inc 76.36K sh · $45.66K · Q2 2026
- Northern Trust Corp 44.16K sh · $26.41K · Q2 2026
- Wells Fargo & Co 2.50K sh · $1.50K · Q2 2026
- UBS Group AG 1.68K sh · $1.00K · Q2 2026
- Morgan Stanley 21 sh · $13 · Q2 2026
- JPMorgan Chase & Co 16 sh · $10 · Q2 2026